Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 16,676 shares at $12.70 ($212K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($212k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.70 | 8,338 | $106K | 50.0% |
| 2 | $12.70 | 8,338 | $106K | 50.0% |
| Total | $12.70 avg | 16,676 | $212K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |